14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
The COVID-19 pandemic is having a profound economic impact across the globe. Entire industries have ...
Read More >
Similar to other disagreements between the NLRB and D.C. Circuit, a tension developed during the las...
Read More >
Report on Supply Chain Compliance 3, no. 4 (February 20, 2020) - The coronavirus that has, at the t...
Read More >
The Internal Revenue Service and the Social Security Administration have announced the cost of livin...
Read More >
On April 24, 2020, Governor Inslee announced a plan to allow current construction projects to be com...
Read More >
New York City is considering proposed legislation that would regulate the use of artificial intellig...
Read More >